Currently out of the existing stock ratings of Dominic Lunn, 6 are a HOLD (33.33%), 5 are a SELL (27.78%), 7 are a BUY (38.89%).

Dominic Lunn

Work Performance Price Targets & Ratings Chart

Analyst Dominic Lunn, currently employed at CREDIT SUISSE, carries an average stock price target met ratio of 71.43% that have a potential upside of 19.29% achieved within 358 days.

Dominic Lunn’s has documented 35 price targets and ratings displayed on 7 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on NVS, Novartis AG ADR at 26-Apr-2023.

Wall Street Analyst Dominic Lunn

Analyst best performing recommendations are on NVO (NOVO NORDISK A/S).
The best stock recommendation documented was for NVO (NOVO NORDISK A/S) at 8/23/2021. The price target of $49.37 was fulfilled within 1 day with a profit of $0.23 (0.46%) receiving and performance score of 4.64.

Average potential price target upside

of $30.37 (75.42%) on CM (CANADIAN IMPERIAL BANK OF COMMERCE).
of $15.89 (13.68%) on AZN (ASTRAZENECA PLC ADR).
of $13.6 (18.86%) on NVS (NOVARTIS AG ADR).

GSK GlaxoSmithKline PLC ADR NVO Novo Nordisk A/S NVS Novartis AG ADR AZN AstraZeneca PLC ADR SNY Sanofi ADR CM Canadian Imperial Bank Of Commerce MOLN Molecular Partners AG ADR

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

James Gordon (BARCLAYS)